ArticleJournal of inflammation research2026

A Real-World Study of Upadacitinib in Anti-TNF Refractory Crohn's Disease: Effectiveness, Persistence, and Safety.

Yuanyuan Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.